Clinical trial
Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty…
NCT00211562 · Augusta University, Other · Terminated
Key facts
| NCT number | NCT00211562 |
|---|---|
| Title | Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids |
| Official title | Reduction of Body Weight in Olanzapine Treated Schizophrenia Patients by Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids |
| Lead sponsor | Augusta University, Other |
| Collaborators | Eli Lilly and Company Industry Medical Service Line ABRC US Department of Veterans Affairs U.S. Fed |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Olanzapine, Omega 3, Vitamin E+C |
| Enrollment | 20 |
| Start date | Oct 1, 2005 |
| Primary completion | Jan 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: